This will change everything... By Brianna Panzica | Saturday, March 29th, 2014 This weekend, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily... Technology Slashes Energy Costs: This Will Change Everything... Investing in Biotech Diagnostics: CombiMatrix (NASDAQ: CBMX) to Rebound in 2014 What if Russia Dumped U.S. Debt?: How Putin Plans to Break America West Texas' Massive Gushers: Check Out These Numbers! Heavy Metal — Putin's War: Palladium Will Run Living Without Russian Gas: Energy at War Advertisement You Made a Big Mistake. Here’s How to Fix It... Over the last 7 months, I've been making the call on a small biotech company with a patented cancer-curing liquid that will soon hit the market. But you missed out. Those who followed my call made 300% returns in 7 months. On the heels of major news concerning this company, I am making a final push for you to get in now while this company still trades under $3 a share. But there isn't much time left. Either you get in now, or miss out again. Go here now to buy this stock. Investing in the Petroplex: Riding the West Texas Oil Boom Natural Gas Worth TRILLIONS: America's Biggest Bull Market A Bottom in Coal: King Coal is Back Military Tech Bull Market: Smart Munitions Technology in the Infantry The Bottom Line | |
This email was sent to ignoble.experiment@arconati.us . You can manage your subscription and get our privacy policy here. Energy and Capital, Copyright © 2014, Angel Publishing LLC, 111 Market Place #720, Baltimore, MD 21202. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Energy and Capital does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info here, including our privacy policy and information on how to manage your subscription. |
This site is an experiment in sharing news and content. Almost everything here came from email newsletters.
Pages
▼
No comments:
Post a Comment
Keep a civil tongue.